Exome Asset Management »

Novo-nordisk A/s-spons Adr call shares owned by Exome Asset Management

Quarter-by-quarter ownership of Novo-nordisk A/s-spons Adr call shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Novo-nordisk A/s-spons Adr call

Tip: Access up to 7 years of quarterly data

All positions including Novo-nordisk A/s-spons Adr call held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novo-nordisk A/s-spons Adr call by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.9M 35k 55.49

More positions owned by Exome Asset Management

Ionis Pharmaceuticals (IONS)
Cytokinetics Com New (CYTK)
Bridgebio Pharma (BBIO)
Cogent Biosciences (COGT)
Guardant Health (GH)
Eli Lilly & Co. (LLY)
I Mab Sponsored Ads (IMAB)
Praxis Precision Medicines I Com New (PRAX)
Vera Therapeutics Cl A (VERA)
Astrazeneca Sponsored Adr (AZN)
Disc Medicine (IRON)
89bio (ETNB)
Apogee Therapeutics (APGE)
Travere Therapeutics (TVTX)
Tenet Healthcare Corp Com New (THC)

View all positions for Exome Asset Management

Top funds holding Novo-nordisk A/s-spons Adr call

Simplex Trading
IMC-Chicago
Optiver Holding B.V.
Group One Trading
Jpmorgan Chase & Co
CMT Capital Markets Trading GmbH
Capital Markets Trading UK
Exome Asset Management
Wealthspan Partners
OVERSEA-CHINESE BANKING Corp
Tennessee Valley Asset Management Partners
Advisor Group Holdings

View all funds holding Novo-nordisk A/s-spons Adr call